None
Quote | Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Last: | $1.55 |
---|---|
Change Percent: | -1.42% |
Open: | $1.43 |
Close: | $1.55 |
High: | $1.57 |
Low: | $1.43 |
Volume: | 135,158 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Adial Pharmaceuticals Inc (NASDAQ:ADIL)
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, ...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Message Board Posts | Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Subject | By | Source | When |
---|---|---|---|
is it bear time? Or do we go bull? | subslover | investorshub | 07/10/2023 5:47:46 AM |
$ADIL MomentumIts now | $oldier Hard | investorshub | 07/06/2023 8:37:50 PM |
$ADIL When is this gonna take off? | mick | investorshub | 07/02/2023 9:38:53 AM |
$ADIL MomentumIts trading up | theorysuit | investorshub | 06/29/2023 5:44:30 PM |
$ADIL Price trading last trade up | mick | investorshub | 06/28/2023 2:28:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Adial Pharmaceuticals Inc Company Name:
ADIL Stock Symbol:
NASDAQ Market:
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, ...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage bioph...